Integrated Proteins Limited (BOM:519606)
India · Delayed Price · Currency is INR 131.40
0.00 (0.00%)
At close: Aug 21, 2026
Integrated Proteins Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 204.83 | 99.36 | 214.96 | 2.37 | 1.67 | - |
Other Revenue | -0.31 | - | -0 | - | - | - |
| 204.52 | 99.36 | 214.96 | 2.37 | 1.67 | - | |
Revenue Growth | -4.86% | -53.78% | 8954.84% | 42.16% | - | - |
Cost of Revenue | 195.12 | 95.01 | 210.25 | 2.22 | 1.47 | - |
Gross Profit | 9.4 | 4.34 | 4.71 | 0.15 | 0.2 | - |
Selling, General & Admin | 0.35 | 0.32 | 0.21 | 0.62 | 0.04 | 0.14 |
Other Operating Expenses | 1.42 | 1.24 | 3.5 | 0.71 | 1.01 | 0.64 |
Operating Expenses | 1.77 | 1.56 | 3.8 | 1.6 | 1.34 | 1.06 |
Operating Income | 7.63 | 2.78 | 0.91 | -1.45 | -1.14 | -1.06 |
Interest Expense | - | - | - | - | - | -0 |
Interest & Investment Income | - | - | 1.53 | 1.56 | 1.56 | 1.56 |
Other Non Operating Income (Expenses) | 0.05 | 0.05 | - | -0 | -0 | 0 |
EBT Excluding Unusual Items | 7.68 | 2.83 | 2.44 | 0.11 | 0.42 | 0.49 |
Gain (Loss) on Sale of Assets | - | - | 0.75 | 0.93 | - | - |
Pretax Income | 7.68 | 2.83 | 3.19 | 1.04 | 0.42 | 0.49 |
Income Tax Expense | 1.8 | 0.58 | 0.69 | 0.15 | 0.11 | 0.13 |
Net Income | 5.88 | 2.25 | 2.5 | 0.89 | 0.31 | 0.37 |
Net Income to Common | 5.88 | 2.25 | 2.5 | 0.89 | 0.31 | 0.37 |
Net Income Growth | 134.25% | -10.00% | 179.95% | 189.00% | -15.34% | 72.17% |
Shares Outstanding (Basic) | 19 | 19 | 4 | 3 | 3 | 3 |
Shares Outstanding (Diluted) | 19 | 19 | 4 | 3 | 3 | 3 |
Shares Change | - | 432.64% | 9.88% | - | - | -0.01% |
EPS (Basic) | 0.31 | 0.12 | 0.71 | 0.28 | 0.10 | 0.11 |
EPS (Diluted) | 0.31 | 0.12 | 0.71 | 0.25 | 0.09 | 0.11 |
EPS Growth | - | -83.10% | 184.00% | 177.78% | -21.01% | 72.19% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 4.60% | 4.37% | 2.19% | 6.36% | 11.98% | - |
Operating Margin | 3.73% | 2.80% | 0.43% | -60.91% | -68.08% | - |
Profit Margin | 2.87% | 2.27% | 1.16% | 37.62% | 18.50% | - |
EBITDA | - | 2.88 | 1.01 | -1.18 | -0.85 | -0.77 |
EBITDA Margin | - | 2.90% | 0.47% | -49.79% | -50.84% | - |
D&A For EBITDA | - | 0.1 | 0.1 | 0.26 | 0.29 | 0.29 |
EBIT | 7.63 | 2.78 | 0.91 | -1.45 | -1.14 | -1.06 |
EBIT Margin | 3.73% | 2.80% | 0.43% | -60.91% | -68.08% | - |
Effective Tax Rate | 23.47% | 20.58% | 21.73% | 14.05% | 26.08% | 26.11% |
Revenue as Reported | 204.57 | 99.41 | 217.34 | 4.86 | 3.23 | 1.56 |
Advertising Expenses | - | - | 0.05 | 0.01 | 0.01 | 0.01 |